QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

EYPT

QT48EyePoint Pharmaceuticals, Inc.
NASDAQ·Healthcare·Biotechnology·USA
Latest market price
13.58
+0.43+3.27%
OverviewShort InterestFilings
EYPTQT48EyePoint Pharmaceuticals, Inc.·NASDAQ
OverviewShort InterestFilings
13.58+3.27%
TA
Loading chart...
Screen all →
VRTX-1.60%$451.63REGN+0.33%$609.94ARGX-1.63%$877.72ALNY-1.64%$278.09RVMD+3.31%$162.99MRNA+3.50%$63.96UTHR-2.70%$536.59BNTX-1.44%$90.89
Snapshot
Index-P/E-EPS (ttm)
-3.50
Insider Own-
Shs Outstand-
Perf Week8.64%
Market Cap1.10BForward P/E-EPS next Y-2.81Insider Trans-Shs Float-Perf Month14.89%
Enterprise Value1.05BPEG0.12EPS next Q-0.94Inst Own-Short Float-Perf Quarter-1.52%
Income-264823639.00P/S144.78EPS this Y-0.85%Inst Trans-Short Ratio-Perf Half Y-19.79%
Sales7.62MP/B4.91EPS next Y20.29%ROA-94.23%Short Interest-Perf YTD-25.67%
Book/sh-P/C-EPS next 5Y-ROE-110.54%52W High19.11 -28.94%Perf Year54.14%
Cash/sh-P/FCF-EPS past 3/5Y-ROIC-112.37%52W Low7.94 71.03%Perf 3Y-
Dividend Est.-EV/EBITDA-4.02Sales past 3/5Y-8.90% -1.83%Gross Margin76.51%Volatility4.32% 4.12%Perf 5Y-
Dividend TTM-EV/Sales137.23EPS Y/Y TTM-50.86%Oper. Margin-3700.89%ATR (14)0.80Perf 10Y-
Dividend Ex-Date-Quick Ratio6.63Sales Y/Y TTM-81.40%Profit Margin-3566.63%RSI (14)57.07Recom2.11
Dividend Gr. 3/5Y-Current Ratio6.66EPS Q/Q-52.31%SMA206.87%Beta0.94Target Price37.50
Payout0.00%Debt/Eq0.09Sales Q/Q-95.83%SMA502.27%Rel Volume1.35Prev Close13.15
Employees165LT Debt/Eq0.07EarningsAug 05SMA200-3.69%Avg Volume958.53KPrice13.58
IPO DateJan 27, 2005Option/ShortYes / YesEPS/Sales Surpr.-25.32% -Net Debt/EBITDA0.22Volume1,290,270Change3.27%
Analyst Ratings
DateActionAnalystRatingTarget
Feb-19-26ReiteratedMizuho Securities$33 → $36
Feb-05-26ReiteratedRBC CapitalOutperform$39
Oct-29-25ReiteratedMizuho Securities$28 → $33
Oct-20-25ReiteratedMizuho Securities$30 → $28
Nov-11-24ReiteratedH.C. WainwrightNeutral$30 → $22
May-13-24ReiteratedH.C. WainwrightNeutral$25 → $30
May-07-24ReiteratedMizuho Securities$30
Aug-04-22ReiteratedH.C. WainwrightNeutral$25
Oct-09-20UpgradeHC Wainwright & Co.Neutral → Buy
Apr-06-20DowngradeB. Riley FBRBuy → Neutral
Latest News
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
6/30/2018
Total Revenue83143
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A224
Gross Profit52940
Selling, General and Administrative Excl. Other535252
Research and Development234221133
Other Operating Expense000
Operating Income-281-243-146
Interest Expense000
Unusual Expense
———
Non-Operating Income (Expense)-19-12-15
Net Income Before Taxes-271-232-131
Income Taxes000
Consolidated Net Income-272-232-131
Net Income From Continuing Operations-271-232-131
Net Income-272-232-131
EPS (Recurring)-3.50-3.17-2.32
EPS (Basic, Before Extraordinaries)-3.50-3.17-2.32
EPS (Diluted)-3.50-3.17-2.32
EBITDA-260-229-129
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio
———
Price To Sales Ratio145.9943.02—
Gross Margin62.5093.5593.02
Operating Margin-3,512.50-783.87-339.53
Net Margin-3,400.00-748.39-304.65
Shares Outstanding867356
Market Capitalization1,1681,334—
Operating Lease Expense
———
Insider Trading Volume
$14.55$13.69$12.83$11.97$11.11● Close Price0.00M0.27M0.54M0.81M1.08MUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Elston GeorgeChief Financial OfficerMay 25 '26Option Exercise0.0015,000095,318May 27 12:00 AM
Ribeiro RamiroChief Medical OfficerApr 17 '26Option Exercise8.264,87440,26080,438Apr 20 12:00 AM
Ribeiro RamiroChief Medical OfficerApr 17 '26Sale15.002,43736,5550Apr 20 12:00 AM
Duker Jay S.President and CEOMar 16 '26Buy13.151,50019,724100,665Mar 16 12:00 AM
Ribeiro RamiroChief Medical OfficerMar 04 '26Option Exercise8.264,87640,27682,875Mar 05 12:00 AM
Ribeiro RamiroChief Medical OfficerMar 04 '26Sale17.872,43843,5720Mar 05 12:00 AM
Ribeiro RamiroChief Medical OfficerFeb 17 '26Option Exercise8.264,87440,26085,313Feb 18 12:00 AM
Ribeiro RamiroChief Medical OfficerFeb 17 '26Sale15.002,43736,5550Feb 18 12:00 AM
Lurker NancyDirectorJan 06 '26Option Exercise0.00150,2660294,346Jan 07 12:00 AM
Duker Jay S.President and CEOJan 06 '26Option Exercise0.0041,586087,806Jan 07 12:00 AM
Elston GeorgeChief Financial OfficerJan 06 '26Option Exercise0.0030,570096,339Jan 07 12:00 AM
Ribeiro RamiroChief Medical OfficerJan 05 '26Option Exercise8.2658,500483,21087,750Jan 07 12:00 AM
Ribeiro RamiroChief Medical OfficerJan 05 '26Sale17.1042,544727,3190Jan 07 12:00 AM
Lurker NancyDirectorJan 05 '26Option Exercise0.0025,3320219,213Jan 06 12:00 AM
Elston GeorgeChief Financial OfficerJan 05 '26Option Exercise0.0030,000085,457Jan 06 12:00 AM
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR